Apr 25, 2018 01:03AM

Apr 12, 2018 01:01AM

Mar 23, 2018 02:00PM

Mar 23, 2018 01:06PM

Mar 23, 2018 01:01PM

Mar 13, 2018 07:34AM

Mar 13, 2018 07:32AM Innovate Biopharmaceuticals appoints June Almenoff, M.D., Ph.D. as Chief Operating Officer and Chief Medical Officer

Jan 15, 2018 01:01AM

Jan 5, 2018 05:54AM

Jan 5, 2018 02:00AM

Jan 5, 2018 01:22AM

Dec 20, 2017 01:01AM

Dec 15, 2017 07:34AM

Dec 15, 2017 07:12AM Takeda and TiGenix announce that Cx601 (darvadstrocel) has received a positive CHMP opinion to treat complex perianal fistulas in Crohn's disease

Dec 14, 2017 07:34PM

Dec 14, 2017 06:22PM

Nov 20, 2017 03:32AM

Nov 16, 2017 01:01AM

Nov 2, 2017 02:01AM

Oct 31, 2017 02:02AM

Oct 23, 2017 06:15AM TiGenix (TIG) Granted FDA Orphan Drug Designation for Cx601

Oct 23, 2017 01:01AM

Oct 5, 2017 06:27AM

Oct 5, 2017 01:01AM

Oct 2, 2017 01:03AM

Sep 28, 2017 01:02AM

Sep 19, 2017 01:03AM

Sep 12, 2017 01:02AM TiGenix strengthens US operations with senior appointments

Sep 5, 2017 01:02AM

Jun 29, 2017 05:31AM

Jun 23, 2017 01:01AM

Jun 20, 2017 06:36AM

Jun 20, 2017 01:01AM

Jun 13, 2017 01:01AM

May 31, 2017 01:01AM TiGenix provides regulatory update on Cx601 EU Marketing Authorization Application procedure

May 10, 2017 01:03AM

May 4, 2017 01:01AM

Apr 6, 2017 01:02AM

Mar 22, 2017 12:51PM

Mar 9, 2017 01:03AM

Mar 7, 2017 01:02AM

Mar 6, 2017 01:01AM TiGenix Provides Update on Cx601 Marketing Authorization Application procedure in Europe

Mar 1, 2017 01:01AM

Feb 27, 2017 01:57AM

Feb 17, 2017 03:10AM

Feb 17, 2017 03:02AM

Feb 6, 2017 01:31AM

Dec 22, 2016 04:03PM

Dec 21, 2016 04:07PM TiGenix: Takeda Exercises its Option to Develop and Commercialize Cx601 in both Japan and Canada

312,667 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All